News - Bill L. Harbert Institute for Innovation and Entrepreneurship

UAB start-up company revolutionizing production of nanofibers

By Amy Jones | Bill L. Harbert Institute for Innovation and Entrepreneurship

Open the doors at TruSpin, and one’s eyes are immediately drawn to a machine spinning out a dense, wispy web onto an enormous spool suspended from above.

While this might look like a mad scientist’s method for making cotton candy, it’s actually the future of nanofiber manufacturing, and the nanofibers created have the potential for seismic impact in the scientific world.

UAB start-up awarded $1 million grant to fight Shigella infections

UAB start-up SunFire Biotechnologies LLC was awarded a grant by the U.S. Department of Defense to continue advancing an assay to support the development of Shigella vaccines.

Collaboration benefits both campus inventors and MBA students

The Harbert Institute of Innovation and Entrepreneurship (HIIE), a campus entity tasked with commercializing innovations developed by scientists, faculty and staff at UAB, recently collaborated with students in Dr. Douglas Ayers' Start-Up Planning and Pitching class in the Collat School of Business MBA program to develop business plans for two UAB technologies. This partnership culminated in presentations to a panel of local business leaders on April 20, 2022.

Apply for fellowship to explore careers in technology transfer, commercialization

Graduate students and postdoctoral fellows in the Innovate Fellows program are trained and compensated to evaluate new inventions on campus through market, prior art and patent analyses to assess commercial merit.

A novel therapy ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet

This therapy, using sustained release of nitric oxide, may be a novel, efficient and safe way to prevent and treat multiple metabolic diseases.

Heart disease: NIH grant to UAB will fund study of safer, more durable stents

Researchers have been awarded a $2.6 million, four-year National Institutes of Health grant to evaluate a safer and more durable stent design, using techniques licensed through the UAB Harbert Institute for Innovation and Entrepreneurship by the UAB spinoff company Endomimetics LLC.

Preclinical demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants

The monoclonal antibody cocktail is deliverable via a nasal dose, and it is also effective against SARS, MERS and several coronavirus cold viruses. The antibodies are engineered for long-acting effectiveness, potentially lasting a year or more when used in humans.

UAB start-up company revolutionizing production of nanofibers

UAB start-up awarded $1 million grant to fight Shigella infections

Collaboration benefits both campus inventors and MBA students

Apply for fellowship to explore careers in technology transfer, commercialization

A novel therapy ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet

Heart disease: NIH grant to UAB will fund study of safer, more durable stents

Preclinical demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants

UAB’s banner year boosted higher by record extramural funding

New life sciences fund announced to spur UAB innovation commercialization

Now is the time to launch or accelerate a startup in Alabama

UAB researcher develops technology to aid COVID-19 vaccine immunity monitoring

UAB startup company receives FDA clearance for liver imaging software